{"title":"Endocrine Emergencies in the Medical Intensive Care Unit.","authors":"Adeel Nasrullah, Syed Azharuddin, Meilin Young, Alexis Kejas, Tiffany Dumont","doi":"10.1097/CNQ.0000000000000411","DOIUrl":"https://doi.org/10.1097/CNQ.0000000000000411","url":null,"abstract":"<p><p>Endocrine emergencies are underdiagnosed and often overlooked amid the management of severe multisystem pathologies in critically ill patients in the medical intensive care unit (ICU). In an appropriate clinical scenario, a low threshold of suspicion should be kept to investigate for various life-threatening, yet completely treatable, endocrinopathies. Prompt identification and treatment of endocrine emergencies such as diabetic ketoacidosis, myxedema coma, thyroid storm, and/or adrenal insufficiency leads to fewer complications, shorter ICU and hospital stay, and improved survival. This review article entails common endocrine emergencies encountered in the ICU and addresses their epidemiology, pathophysiology, clinical presentation and management.</p>","PeriodicalId":10789,"journal":{"name":"Critical Care Nursing Quarterly","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10134734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eric Bucklew, Ali Noory, Nazli Okumus, Srikanth Radhakrishnan, Sunita Mahabir, Gursharan Samra, Karen Dysert, Tariq Cheema, Valentyna Ivanova
{"title":"Acute Cardiac Emergencies.","authors":"Eric Bucklew, Ali Noory, Nazli Okumus, Srikanth Radhakrishnan, Sunita Mahabir, Gursharan Samra, Karen Dysert, Tariq Cheema, Valentyna Ivanova","doi":"10.1097/CNQ.0000000000000405","DOIUrl":"https://doi.org/10.1097/CNQ.0000000000000405","url":null,"abstract":"<p><p>Acute cardiac emergencies are life threatening. The initial responses to acute cardiac emergencies must be rapid, efficient, skillful, and well-planned. The goal of this article is to provide information that can be used to facilitate the prompt recognition and treatment of the most common acute cardiac emergencies.</p>","PeriodicalId":10789,"journal":{"name":"Critical Care Nursing Quarterly","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10132642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Brian W Gilbert, Jacob A Reeder, Tessa R Reynolds, Caitlynn A Tabaka, Megan A Rech
{"title":"Anticoagulation Monitoring in the Intensive Care Unit.","authors":"Brian W Gilbert, Jacob A Reeder, Tessa R Reynolds, Caitlynn A Tabaka, Megan A Rech","doi":"10.1097/CNQ.0000000000000394","DOIUrl":"https://doi.org/10.1097/CNQ.0000000000000394","url":null,"abstract":"<p><p>Patients with critical illness often display variable hypo- and hypercoagulable sequalae requiring intense monitoring and anticoagulation pharmacotherapy to prevent or treat inappropriate clot formation. It is imperative to understand the various stages of the clotting cascade and where each pharmacotherapy agent exerts its therapeutic effect. Common coagulation tests are utilized to monitor the areas of the clotting cascade and the effects that anticoagulant pharmacotherapy exhibits. Many novel coagulation tests are also in development. The purpose of this narrative review is to evaluate commonly utilized coagulation tests that monitor anticoagulation while in the intensive care unit.</p>","PeriodicalId":10789,"journal":{"name":"Critical Care Nursing Quarterly","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39656758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hannah M Brokmeier, Erin D Wieruszewski, Scott D Nei, Theodore O Loftsgard, Patrick M Wieruszewski
{"title":"Hemostatic Management in Extracorporeal Membrane Oxygenation.","authors":"Hannah M Brokmeier, Erin D Wieruszewski, Scott D Nei, Theodore O Loftsgard, Patrick M Wieruszewski","doi":"10.1097/CNQ.0000000000000396","DOIUrl":"https://doi.org/10.1097/CNQ.0000000000000396","url":null,"abstract":"<p><p>The use of extracorporeal membrane oxygenation (ECMO) for acute cardiac and/or respiratory failure has grown exponentially in the past several decades. Systemic anticoagulation is a fundamental element of caring for ECMO patients. Hemostatic management during ECMO walks a fine line to balance the risk of safe and effective anticoagulant delivery to mitigate thromboembolic complications and minimizing hemorrhagic sequelae. This review discusses the pharmacology, monitoring parameters, and special considerations for anticoagulation in patients requiring ECMO.</p>","PeriodicalId":10789,"journal":{"name":"Critical Care Nursing Quarterly","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10132124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Foreword.","authors":"G Morgan Jones","doi":"10.1097/CNQ.0000000000000402","DOIUrl":"https://doi.org/10.1097/CNQ.0000000000000402","url":null,"abstract":"","PeriodicalId":10789,"journal":{"name":"Critical Care Nursing Quarterly","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39656757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Andrew C Stone, Joshua W Gaborcik, Megan E Smetana
{"title":"Anticoagulation Considerations in Liver Disease.","authors":"Andrew C Stone, Joshua W Gaborcik, Megan E Smetana","doi":"10.1097/CNQ.0000000000000398","DOIUrl":"https://doi.org/10.1097/CNQ.0000000000000398","url":null,"abstract":"<p><p>Coagulopathy of liver disease is a complex pathology that may result in thrombosis and/or bleeding complications. Routine laboratory values are not always reflective of the degree of these risks. Additionally, prophylaxis and treatment of venous thromboembolism in patients with cirrhosis require careful evaluation when selecting and monitoring drug therapy for these indications. Therefore, this article aims to provide insight regarding coagulopathy of liver disease, influence on laboratory values, and anticoagulant therapy considerations for critical care nurses assuming care for patients with cirrhosis.</p>","PeriodicalId":10789,"journal":{"name":"Critical Care Nursing Quarterly","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10132122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Keaton S Smetana, Jacob Counts, Angad Sodhi, Casey C May
{"title":"Review of Target-Specific Anticoagulation Reversal Agents.","authors":"Keaton S Smetana, Jacob Counts, Angad Sodhi, Casey C May","doi":"10.1097/CNQ.0000000000000400","DOIUrl":"https://doi.org/10.1097/CNQ.0000000000000400","url":null,"abstract":"<p><p>Bleeding related to direct oral anticoagulants accounts for nearly half of emergency department visits annually and until recently there were no reversal antidotes available. As there continues to be a shift in prescribing practices away from warfarin, it is essential to have these reversal agents readily available for the treatment of life-threatening bleeds associated with these anticoagulants. In addition, for agents that continue to lack a targeted reversal agent (eg, low-molecular-weight heparin, antiplatelets, and new antithrombotics), it is imperative that research continues to evaluate improved reversal strategies. This review focuses on target-specific anticoagulation reversal agents currently available in the United States (protamine, idarucizumab, and andexanet alfa) and summarizes agents that are in the pipeline for these anticoagulants and antiplatelets.</p>","PeriodicalId":10789,"journal":{"name":"Critical Care Nursing Quarterly","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10187882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neil A Roe, Adam L Wiss, Sarah Volgas, Joanna Q Hudson
{"title":"Review of Anticoagulation in Continuous Renal Replacement Therapy.","authors":"Neil A Roe, Adam L Wiss, Sarah Volgas, Joanna Q Hudson","doi":"10.1097/CNQ.0000000000000397","DOIUrl":"https://doi.org/10.1097/CNQ.0000000000000397","url":null,"abstract":"<p><p>Continuous renal replacement therapy is an important, yet challenging, treatment of critically ill patients with kidney dysfunction. Clotting within the dialysis filter or circuit leads to time off therapy and impaired delivery of prescribed treatment. Anticoagulation can be used to prevent this complication; however, doing so introduces risk for unintended complications such as bleeding or metabolic derangements in patients who are already critically ill. A thorough understanding of indications, therapeutic options, and monitoring principles is necessary for safe and effective use of this strategy. This review provides clinicians important information regarding when to anticoagulate, differences in pharmacologic agents, recommended doses, routes of drug delivery, and appropriate laboratory monitoring for patients receiving anticoagulation to support continuous renal replacement therapy.</p>","PeriodicalId":10789,"journal":{"name":"Critical Care Nursing Quarterly","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39959741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lauren D Briete, William F Towers, Rachel Bone, Ranjit Nair, Mackenzie Steck, B Tate Cutshall, Samarth P Shah
{"title":"Perioperative Anticoagulation Management.","authors":"Lauren D Briete, William F Towers, Rachel Bone, Ranjit Nair, Mackenzie Steck, B Tate Cutshall, Samarth P Shah","doi":"10.1097/CNQ.0000000000000395","DOIUrl":"https://doi.org/10.1097/CNQ.0000000000000395","url":null,"abstract":"<p><p>Management of anticoagulation in individuals undergoing operative procedures is a complex situation. Each case should be assessed individually with proper risk assessment, monitoring, and plan for perioperative and postoperative anticoagulation. Clinical evidence for the management of these patients is relatively scarce, and clinicians are often assessing each individual case with minimal guidance. This review provides nurses with a summary of available literature on the assessment, laboratory monitoring, timing of adjusting anticoagulation, and bridging prior to procedures. In addition to general perioperative anticoagulation management, this review discusses perioperative management in special populations and provides a summary on principles when anticoagulation should be resumed following a procedure.</p>","PeriodicalId":10789,"journal":{"name":"Critical Care Nursing Quarterly","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10187878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
求助内容：
应助结果提醒方式：